Rockwell Medical, Inc.
RMTI
$7.07
$0.233.36%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -30.75% | -31.76% | -23.60% | -6.79% | 12.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -30.75% | -31.76% | -23.60% | -6.79% | 12.82% |
| Cost of Revenue | -30.07% | -31.48% | -21.98% | -11.18% | 3.63% |
| Gross Profit | -33.86% | -33.11% | -31.54% | 21.51% | 90.45% |
| SG&A Expenses | -3.13% | -2.79% | 1.89% | 10.64% | 13.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -25.39% | -26.70% | -18.25% | -8.42% | 4.26% |
| Operating Income | -941.08% | -871.55% | -929.66% | 58.23% | 108.71% |
| Income Before Tax | -1,946.97% | -1,007.08% | -346.28% | 56.01% | 96.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,946.97% | -1,007.08% | -346.28% | 56.01% | 96.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,946.97% | -1,007.08% | -346.28% | 56.01% | 96.86% |
| EBIT | -941.08% | -871.55% | -929.66% | 58.23% | 108.71% |
| EBITDA | -196.39% | -189.63% | -194.80% | 201.24% | 157.96% |
| EPS Basic | -632.37% | -339.69% | -175.96% | 55.64% | 94.60% |
| Normalized Basic EPS | -1,992.69% | -674.51% | -212.23% | 65.76% | 98.10% |
| EPS Diluted | -450.78% | -271.88% | -157.41% | 51.03% | 92.68% |
| Normalized Diluted EPS | -1,571.99% | -609.41% | -201.57% | 65.06% | 97.61% |
| Average Basic Shares Outstanding | 15.64% | 15.81% | 14.45% | 14.57% | 26.09% |
| Average Diluted Shares Outstanding | 13.48% | 13.57% | 12.16% | 13.77% | 28.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |